SAVA Cassava Sciences Inc

Price (delayed)

$22.05

Market cap

$953.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.32

Enterprise value

$831.98M

Cassava Sciences' mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to ...

Highlights

Cassava Sciences's debt has plunged by 100% YoY

The quick ratio has dropped by 70% year-on-year but it is up by 4.4% since the previous quarter

Cassava Sciences's equity has decreased by 40% YoY and by 11% from the previous quarter

The net income has contracted by 28% YoY

Sector: Healthcare

Industry: Biotechnology

Website: http://www.paintrials.com

Peers: OMER OMGA

Key stats

What are the main financial stats of SAVA

Market

Shares outstanding

43.23M

Market cap

$953.12M

Enterprise value

$831.98M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

6.76

Price to sales (P/S)

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

Earnings

Revenue

EBIT

-$97.22M

EBITDA

-$95.69M

Free cash flow

-$82.44M

Per share

EPS

-$2.32

Free cash flow per share

-$1.97

Book value per share

$3.26

Revenue per share

TBVPS

$3.61

Balance sheet

Total assets

$151.66M

Total liabilities

$14.2M

Debt

Equity

$137.47M

Working capital

$115.44M

Liquidity

Debt to equity

Current ratio

9.13

Quick ratio

8.53

Net debt/EBITDA

1.27

Margins

EBITDA margin

N/A

Gross margin

N/A

Net margin

N/A

Operating margin

N/A

Efficiency

Return on assets

-52.6%

Return on equity

-57.5%

Return on invested capital

-701.8%

Return on capital employed

-70.7%

Return on sales

N/A

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

SAVA stock price

How has the Cassava Sciences stock price performed over time

Intraday

-0.05%

1 week

-1.3%

1 month

7.14%

1 year

-1.17%

YTD

-2.04%

QTD

8.67%

Financial performance

How have Cassava Sciences's revenue and profit performed over time

Revenue

Gross profit

Operating income

-$105.96M

Net income

-$97.22M

Gross margin

N/A

Net margin

N/A

Cassava Sciences's operating income has decreased by 32% YoY

The net income has contracted by 28% YoY

Growth

What is Cassava Sciences's growth rate over time

Valuation

What is Cassava Sciences stock price valuation

P/E

N/A

P/B

6.76

P/S

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

Cassava Sciences's EPS has decreased by 22% YoY

Cassava Sciences's equity has decreased by 40% YoY and by 11% from the previous quarter

SAVA's P/B is 23% above its last 4 quarters average of 5.5 and 17% above its 5-year quarterly average of 5.8

Efficiency

How efficient is Cassava Sciences business performance

SAVA's ROIC has shrunk by 125% YoY and by 20% QoQ

SAVA's return on equity has dropped by 66% year-on-year and by 15% since the previous quarter

Cassava Sciences's ROA has plunged by 57% YoY and by 13% from the previous quarter

Dividends

What is SAVA's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for SAVA.

Financial health

How did Cassava Sciences financials performed over time

SAVA's total liabilities has soared by 95% YoY but it is down by 18% from the previous quarter

The quick ratio has dropped by 70% year-on-year but it is up by 4.4% since the previous quarter

Cassava Sciences's debt is 100% less than its equity

Cassava Sciences's debt has plunged by 100% YoY

Cassava Sciences's equity has decreased by 40% YoY and by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.